Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-09 4:30 pm Sale | 13G | AC IMMUNE SA SHS ACIU | AFFIRIS AG in Liqu | 6,578,100 6.66% | -146,740 (-2.18%) | View |
| 2023-12-19 4:53 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 14,571,236 14.8% | 7,142,857 (+96.16%) | View |
| 2023-02-14 5:15 pm Sale | 13G | AC IMMUNE SA SHS ACIU | AFFIRIS AG in Liqu | 6,724,840 8.06% | -1,895,317 (-21.99%) | View |
| 2023-02-13 5:53 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.9% | 366,000 (+5.18%) | View |
| 2023-02-10 4:01 pm Sale | 13G | AC IMMUNE SA SHS ACIU | dievini Hopp BioTech holding GmbH & Co KG | 16,316,742 19.5% | -1,724,258 (-9.56%) | View |
| 2023-01-27 4:41 pm Unchanged | 13G | AC IMMUNE SA SHS ACIU | ELI LILLY & Co LLY | 3,615,328 4.3% | 0 (Unchanged) | View |
| 2022-02-14 1:41 pm Sale | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,062,379 9.7% | -854,279 (-10.79%) | View |
| 2022-02-14 1:37 pm Sale | 13G | AC IMMUNE SA SHS ACIU | EcoR1 Capital LLC | 749,585 0.9% | -3,952,575 (-84.06%) | View |
| 2021-08-05 5:15 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | AFFIRIS AG in Liqu | 8,620,157 10.1% | 8,620,157 (New Position) | View |
| 2021-02-12 4:50 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | ELI LILLY & Co LLY | 3,615,328 5% | 3,615,328 (New Position) | View |
| 2021-02-12 10:59 am Sale | 13G | AC IMMUNE SA SHS ACIU | dievini Hopp BioTech holding GmbH & Co KG | 18,041,000 25.1% | -174,750 (-0.96%) | View |
| 2021-01-22 4:27 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | EcoR1 Capital LLC | 4,702,160 6.6% | 4,702,160 (New Position) | View |
| 2021-01-14 4:48 pm Sale | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,916,658 11% | -3,425,847 (-30.20%) | View |
| 2020-02-14 3:07 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 11,342,505 16.8% | 44,594 (+0.39%) | View |
| 2020-02-07 11:12 am Sale | 13G | AC IMMUNE SA SHS ACIU | FMR LLC | 67,457 0.099% | -5,545,301 (-98.80%) | View |
| 2020-02-06 3:16 pm Unchanged | 13G | AC IMMUNE SA SHS ACIU | dievini Hopp BioTech holding GmbH & Co KG | 18,215,750 27% | 0 (Unchanged) | View |
| 2019-09-16 5:16 pm Purchase | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 11,297,911 16.7% | 3,842,377 (+51.54%) | View |